Showing
1 - 9
results of
9
for search '
Al-Fayoumi S
'
Skip to content
Home
Collections
High Impact Articles
Jawi Collection
Malay Medicine
Search Options
UiTM Open Access
Search by UiTM Scopus
Advanced Search
Search by Category
Discovery Service
Sources
UiTM Journals
List UiTM Journal in IR
Statistic
About
Open Access
Creative Commons Licenses
COKI | Malaysia Open Access
Report Technical
User Guide
Contact Us
Search Tips
FAQs
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Author
Al-Fayoumi S
Showing
1 - 9
results of
9
for search '
Al-Fayoumi S
'
, query time: 0.07s
Refine Results
Sort
Relevance
Date Descending
Date Ascending
Call Number
Author
Title
1
Security performance analysis and enhancement of wireless authentication protocol based on digital signature scheme
by
Al
-
Fayoumi
, Mustafa Ahmad
Published 2009
Get full text
2
The application of quality management in the financial services sector in Jordan
by
Arwa Ayyash
,
Nedal
Al
-
Fayoumi
,
Bana Abuzayed
Published 2012-10-01
Get full text
Article
3
Assessment of the Jordanian banking sector within the context of GATS agreement
by
Nedal Ahmed
Al
-
Fayoumi
,
Bana M. Abuzayed
Published 2009-09-01
Get full text
Article
4
Pilot study of the antifibrotic effects of the multikinase inhibitor pacritinib in a mouse model of liver fibrosis
by
Al
-
Fayoumi
S
,
Hashiguchi T
,
Shirakata Y
,
Mascarenhas J
,
Singer JW
Published 2018-05-01
Get full text
Article
5
Secure E-Test Scheme
by
Mohammad A
AL
-
Fayoumi
,
Sattar J Aboud
,
Mamoun S. AL Rababaa
Published 2007-12-01
Get full text
Article
6
Techniques of medical image encryption taxonomy
by
Ahmad, A.
,
Al
-
Fayoumi
, M.A
,
Keshta, I.
,
Odeh, A.
Published 2022
Call Number:
Loading...
Located:
Loading...
View Fulltext in Publisher
Article
7
Comprehensive kinase profile of pacritinib, a nonmyelosuppressive Janus kinase 2 inhibitor
by
Singer J
,
Al
-
Fayoumi
S
,
Ma H
,
Komrokji R
,
Mesa R
,
Verstovsek S
Published 2016-08-01
Get full text
Article
8
Comparative phenotypic profiling of the JAK2 inhibitors ruxolitinib, fedratinib, momelotinib, and pacritinib reveals distinct mechanistic signatures.
by
Jack W Singer
,
Suliman
Al
-
Fayoumi
,
Jason Taylor
,
Sharlene Velichko
,
Alison O'Mahony
Published 2019-01-01
Get full text
Article
9
Phase 1/2 study of pacritinib, a next generation JAK2/FLT3 inhibitor, in myelofibrosis or other myeloid malignancies
by
Srdan Verstovsek
,
Olatoyosi Odenike
,
Jack W. Singer
,
Tanya Granston
,
Suliman
Al
-
Fayoumi
,
H. Joachim Deeg
Published 2016-12-01
Get full text
Article
Search Tools:
Get RSS Feed
—
Email this Search
Related Subjects
Digital medical images
Genetic algorithms
Internet of medical things
S-box
Loading...